Search results
Results from the WOW.Com Content Network
CytoJournal is a peer-reviewed PubMed-indexed open access online scientific journal on cytology that publishes research articles and information related to all aspects of diagnostic cytopathology, including topics such as molecular cytopathology. It is owned and supported by a non-profit organization (Cytopathology Foundation Inc, USA).
The journal is abstracted and indexed in Science Citation Index, Index Medicus (Medline), Scopus, Google Scholar and EMBASE/Excerpta Medica. [1] According to the Journal Citation Reports, its 2022 impact factor is 3.4 ranking it 28th out of 76 journals in the category "Pathology" [2]
Cancer Cytopathology is a monthly peer-reviewed scientific journal which covers practice of cytopathology and its related oncology-based disciplines. It is one of three official journals of the American Cancer Society and is published by Wiley-Blackwell on behalf of the society. The current editor-in-chief is William C. Faquin.
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
While these journals still did not receive an impact factor until the next year, they did contribute citations to the calculation of other journals' impact factors. [ 4 ] [ 5 ] In July 2022, Clarivate announced that journals in the ESCI obtain an impact factor effective from JCR Year 2022 first released in June 2023.
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
The values for Nature journals lie well above the expected ca. 1:1 linear dependence because those journals contain a significant fraction of editorials. CiteScore was designed to compete with the two-year JCR impact factor, which is currently the most widely used journal metric. [7] [8] Their main differences are as follows: [9]
The journal was established in 1999 as The American Journal of Pathology, Part B, with Nelson Fausto (University of Washington) as founding editor. [1] [2] [3] According to the Journal Citation Reports, the journal has a 2021 impact factor of 5.341. [4]